Wimalawansa S
Biology (Basel). 2024; 13(10).
PMID: 39452140
PMC: 11504239.
DOI: 10.3390/biology13100831.
Silva-Santos Y, Pagni R, Gamon T, de Azevedo M, Bielavsky M, Darido M
Front Pharmacol. 2024; 15:1414406.
PMID: 39070798
PMC: 11282493.
DOI: 10.3389/fphar.2024.1414406.
Spoto S, Basili S, Cangemi R, Yuste J, Lucena F, Romiti G
Cells. 2024; 13(11.
PMID: 38891025
PMC: 11172186.
DOI: 10.3390/cells13110892.
Shukla A, Awasthi K, Usman K, Banerjee M
World J Diabetes. 2024; 15(4):606-622.
PMID: 38680697
PMC: 11045416.
DOI: 10.4239/wjd.v15.i4.606.
Sharun K, Tiwari R, Yatoo M, Natesan S, Megawati D, Singh K
Narra J. 2024; 2(3):e92.
PMID: 38449903
PMC: 10914132.
DOI: 10.52225/narra.v2i3.92.
Pathological Interplay and Clinical Complications between COVID-19 and Cardiovascular Diseases: An Overview in 2023.
Zhou S, Zhang A, Liao H, Liu Z, Yang F
Cardiology. 2023; 149(1):60-70.
PMID: 37586358
PMC: 11251668.
DOI: 10.1159/000533359.
COVID-19-Triggered Acute Liver Failure and Rhabdomyolysis: A Case Report and Review of the Literature.
Matsuki Y, Sugihara T, Kihara T, Kawakami T, Kitaura T, Takata T
Viruses. 2023; 15(7).
PMID: 37515132
PMC: 10384858.
DOI: 10.3390/v15071445.
Potential Drugs in COVID-19 Management.
Gasmi A, Noor S, Menzel A, Khanyk N, Semenova Y, Lysiuk R
Curr Med Chem. 2023; 31(22):3245-3264.
PMID: 37461346
DOI: 10.2174/0929867331666230717154101.
Association of RASis and HMG-CoA reductase inhibitors with clinical manifestations in coronavirus disease 2019 patients: Results from the Khorshid Coronavirus Disease Cohort Study.
Iraj B, Moravejolahkami A, Sami R, Riahinezhad M, Tasdighi Z, Toghyani A
J Res Med Sci. 2023; 28:15.
PMID: 37064792
PMC: 10098137.
DOI: 10.4103/jrms.jrms_373_22.
Renin-Angiotensin System Inhibitors and the COVID-19 Pandemic.
Muchaili L, Mweene B, Masenga S
Am J Hypertens. 2023; 36(7):360-362.
PMID: 37010128
PMC: 10267615.
DOI: 10.1093/ajh/hpad031.
Renin-Angiotensin-Aldosterone Axis Inhibition Improves Outcome of Diabetic Patients with Chronic Hypertension and COVID-19: An Iranian Perspective.
Kheyri Z, Alizadeh M, Akbarpour S, Hosamirudsari H, Niya M, Aliasgharpour F
Adv Biomed Res. 2023; 11:109.
PMID: 36798924
PMC: 9926032.
DOI: 10.4103/abr.abr_177_21.
The effect of renin-angiotensin-aldosterone system inhibitors in patients with hypertension and COVID-19: A meta-analysis of randomized controlled trials and propensity score-matched studies.
Zhang K, Cao L, Xuan N, Huang T, Tian B, Cui W
J Intensive Med. 2023; 2(4):282-290.
PMID: 36785646
PMC: 9212589.
DOI: 10.1016/j.jointm.2022.05.004.
COVID-19's immuno-pathology and cardiovascular diseases.
Mehrabi Nasab E, Aghajani H, Makoei R, Athari S
J Investig Med. 2023; 71(2):71-80.
PMID: 36647329
PMC: 9850087.
DOI: 10.1177/10815589221141841.
Synergistic effect of myocardial injury and mid-regional proAdrenomedullin elevation in determining clinical outcomes of SARS-CoV-2 patients.
Spoto S, Mangiacapra F, DAvanzo G, Lemme D, Bustos Guillen C, Abbate A
Front Med (Lausanne). 2022; 9:929408.
PMID: 36388948
PMC: 9643355.
DOI: 10.3389/fmed.2022.929408.
Whole exome sequencing identifies a rare variant in MAS1 gene in a subject with lethal COVID-19.
Azzara A, Cassano I, Tirindelli M, Nobile C, Schittone V, Paccagnella E
Gene Rep. 2022; 29:101705.
PMID: 36348959
PMC: 9633625.
DOI: 10.1016/j.genrep.2022.101705.
Increased circulating microparticles contribute to severe infection and adverse outcomes of COVID-19 in patients with diabetes.
Sun H, Du Y, Kumar R, Buchkovich N, He P
Am J Physiol Heart Circ Physiol. 2022; 323(6):H1176-H1193.
PMID: 36269646
PMC: 9678425.
DOI: 10.1152/ajpheart.00409.2022.
Role of endothelial dysfunction in the severity of COVID‑19 infection (Review).
Kadiyska T, Tourtourikov I, Dabchev K, Cherneva R, Stoynev N, Hadjiolova R
Mol Med Rep. 2022; 26(5).
PMID: 36196882
PMC: 9551399.
DOI: 10.3892/mmr.2022.12867.
Tetraspanin-enriched Microdomain Containing CD151, CD9, and TSPAN 8 - Potential Mediators of Entry and Exit Mechanisms in Respiratory Viruses Including SARS-CoV-2.
Malla R, Kamal M
Curr Pharm Des. 2022; 28(46):3649-3657.
PMID: 36173052
DOI: 10.2174/1381612828666220907105543.
Antiviral potential of diminazene aceturate against SARS-CoV-2 proteases using computational and in vitro approaches.
Santos E, Silva P, Sousa P, Aquino C, Pacheco G, Teixeira L
Chem Biol Interact. 2022; 367:110161.
PMID: 36116513
PMC: 9476334.
DOI: 10.1016/j.cbi.2022.110161.
Does COVID-19 lockdowns have impacted on global dengue burden? A special focus to India.
Sharma H, Ilyas A, Chowdhury A, Poddar N, Chaudhary A, Shilbayeh S
BMC Public Health. 2022; 22(1):1402.
PMID: 35869470
PMC: 9304795.
DOI: 10.1186/s12889-022-13720-w.
